CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $622,106,000 | -53.0% | 361 | -95.3% | 0.06% | -53.9% |
| Q2 2021 | $1,324,745,000 | +153.2% | 7,662 | -37.9% | 0.13% | +50.6% |
| Q1 2020 | $523,169,000 | +41094.4% | 12,336 | +39693.5% | 0.08% | – |
| Q3 2019 | $1,270,000 | -13.0% | 31 | 0.0% | 0.00% | – |
| Q2 2019 | $1,460,000 | +31.9% | 31 | 0.0% | 0.00% | – |
| Q1 2019 | $1,107,000 | +25.1% | 31 | 0.0% | 0.00% | – |
| Q4 2018 | $885,000 | -35.6% | 31 | 0.0% | 0.00% | – |
| Q3 2018 | $1,374,000 | -24.6% | 31 | 0.0% | 0.00% | – |
| Q2 2018 | $1,822,000 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |